Abstract
Background. Immediate breast reconstruction (IBR) by means of skin expander is currently one of the most widely used methods of breast reconstruction in mastectomized patients. However, given that many breast cancer patients usually receive adjuvant chemotherapy, the adoption of IBR raises new questions concerning possible cumulative toxicity. The present study reports our experience in the use of concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expander after mastectomy for breast cancer and the acute cumulative toxicity of the treatments.
Methods. We evaluated a consecutive series of 52 breast cancer patients who have received IBR by skin expander after radical mastectomy and adjuvant chemotherapy concurrently during skin expansion between 1995 and 1998 (IBR/CT group). We identified two series of control patients treated during the same period: 51 consecutive patients undergoing radical mastectomy and IBR without adjuvant chemotherapy (IBR group) and 63 consecutive patients undergoing radical mastectomy and adjuvant chemotherapy without IBR (CT group). For each patient, we evaluated the incidence of surgical complications and chemotherapy's side effects and dose intensity.
Results. The interval between surgery and the start of expander inflation was similar in IBR/CT (range 0–19, median 5 days) and IBR groups (range 0–40, median 5 days) and the timing of inflation was not influenced by chemotherapy. The overall incidence of surgical complications in patients undergoing IBR was low: seroma in eight cases, infection in one, skin necrosis in one, expander rupture in two and erythema in three. There were no statistically significant differences in the distribution of complications between the IBR/CT and IBR groups. The dose intensity of chemotherapy was similar between IBR/CT and CT groups, with a median dose intensity of 96% and 95% of the projected dose, respectively. The only statistically significant difference in terms of chemotherapy side effects (p=0.03) was that stomatitis was more frequent and intense in the CT than in the IBR/CT group.
Conclusions. Concurrent treatment with IBR and adjuvant chemotherapy appears feasible and safe, it does not increase acute surgical complications or chemotherapy side effects, and does not require any changes in dose intensity or the timing of inflation.
Similar content being viewed by others
References
Irwig L, Bennetts A: Quality of life after breast conservation or mastectomy: a systematic review. Aust N Z J Surg 67: 750–754, 1997
Noone RB, Frazier TG, Hayward CZ, Skiles MS: Patient acceptance of immediate reconstruction following mastectomy. Plast Reconstr Surg 69: 632–640, 1982
Dean C, Chetty U, Forrest APM: Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet 1: 459–462, 1983
Stevens LA, McGrath MH, Druss RG, Kister SJ, Gump FE, Forde KA: The psychological impact of immediate breast reconstruction for women with early breast cancer. Plast Reconstr Surg 73: 619–626, 1984
Schain WS, Wellisch DK, Pasnau RO, Landsverk J: The sooner the better: a study of psychological factors in women undergoing immediate versus delayed breast reconstruction. Am J Psychiatry 142: 40–46, 1985
Wellisch DK, SchainWS, Noone RB, Little JWI: Psychosocial correlates of immediate versus delayed reconstruction of the breast. Plast Reconstr Surg 76: 713–718, 1985
Bailey MH, Smith JW, Casas L, Johnson P, Serra E, de la Fuente R, Sullivan M, Scanlon EF: Immediate breast reconstruction: reducing the risks. Plast Reconstr Surg 83: 845–851, 1989
Yule GJ, Concannon MJ, Croll GH, Puckett CL: Is there liability with chemotherapy following immediate breast reconstruction? Plast Reconstr Surg 97: 969–973, 1996
Wey PD, Highstein JB, Borah GL: Immediate breast reconstruction in the high-risk adjuvant setting. Ann Plast Surg 38: 342–344, 1997
Furey PC, MacGillivray DC, Castiglione CL, Allen L: Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 55: 194–197, 1994
Hoffluan JP, Kusiak J, Boraas M, Genter B, Steuber K, Weese JL, Keidan RD, Eisenberg BL, Cox T, Litwin S: Risk factors for immediate prosthetic postmastectomy reconstruction. Am Surg 57: 514–521, 1991
Longo DL, Duffey PL, DeVita VT, Wesley MN, Hubbard SM, Young RC: The calculation of actual or received dose intensity: A comparison of published method. J Clin Oncol 9: 2042–2051, 1991
Silverstein MJ, Murphy GP, Bostwick J, Byrd BFJ, Snyderman RK, Weber WE: Breakout II: Breast reconstruction: State of the art for the 1990's. Cancer 68: 1180–1181, 1991
Argenta LC, Marks MW, Grabb WC: Selective use of serial expansion in breast reconstruction. Ann Plast Surg 11: 188–195, 1983
Albo R, Gruber R, Kahn R: Immediate breast reconstruction after modified mastectomy for carcinoma of the breast. Am J Surg 140: 131–136, 1980
Georgiade G, Georgiade N, McCarty KS, Seigler HF: Rationale for immediate reconstruction of the breast following modified radical mastectomy. Ann Plast Surg 8: 20–28, 1982
Frazier TG, Noone RB: An objective analysis of immediate simultaneous reconstruction in the treatment of carcinoma of the breast. Cancer 55: 1202–1205, 1985
Feller WF, Holt R, Spear S, Little JW: Modified radical mastectomy with immediate breast reconstruction. Am Surg 52: 129–133, 1986
Noone RB, Murphy JB, Spear SL, Little JWI: A six year experience with immediate reconstruction after mastectomy for cancer. Plast Reconstr Surg 76: 258–269, 1985
Johnson CH, van Heerden JA, Donohue JH, Martin JK, Jackson IT, I1strup DM: Oncological aspects of immediate breast reconstruction following mastectomy for malignancy. Am Surg 24: 819–824, 1989
Kroll SS, Ames F, Singletary SE, Schusterman MA: The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet 172: 17–20, 1991
Devereux DF, Thibault L, Boretos J, Brennan MF: The quantitative and qualitative impairment of wound healing by Adriamycin. Cancer 43: 932–938, 1979
Ferguson MK: The effect of antineoplastic agents on wound healing. Surg Gynecol Obstet 154: 421–429, 1982
Lawrence WT, Talbot TL, Norton JA: Preoperative or postoperative doxorubicin hydrochloride (Adriamycin): which is better for wound healing? Surgery 100: 9–13, 1986
Pollack SV: Systemic drugs and nutritional aspects of wound healing. Clin Dermatol 2: 68–80, 1984
Angerpointner TA, Schmidt P, Donhauser U, Haas R, Bender-Gotze C: Postoperative course in children with malignant tumors following preoperative chemotherapy. Klin Pediatr 201: 209–212, 1989
McDonald DJ, Capanna R, Gherlinzoni F, Bacci G: Influence of chemotherapy on perioperative complications in limb salvage surgery for bone tumors. Cancer 65: 1509–1516, 1990
FowlerWC, Langer CJ, CurranWJJ, Keller SM: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55: 986–989, 1993
Georgiade GS, Riefkohl R, Cox E, McCarty KS, Seigler HF, Georgiade NG, Snowhite JC: Long-term clinical outcome of immediate breast reconstruction after mastectomy. Plast Reconstr Surg 76: 415–420, 1985
Noone RB, Frazier TG, Noone GC, Blanchet NP, Murphy JB, Rose D: Recurrence of breast carcinoma following immediate reconstruction: a 13-year review. Plast Reconstr Surg 93: 96–106, 1994
van Heerden JA, Jackson IT, Martin JK, Fisher I: Surgical technique and pitfalls of breast reconstruction immediately after mastectomy for carcinoma: initial experience. Mayo Clin Proc 62: 185–191, 1987
Rheingold L, Yoo RP, Courtiss EH: Experience with 326 inflatable breast implants. Plast Reconstr Surg 93: 118–122, 1994
Forouhi P, Dixon JM, Leonard RCF, Chetty U: Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg 82: 79–82, 1995
Danforth DNj, Lippman ME, McDonald H, Bader J, Egan E, Lampert M, Steinberg SM, Swain SM: Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg 56: 6–11, 1990
Broadwater JR, Edwards MJ, Kuglen C, Hortobagyi GN, Ames FC, Balch CM: Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Ann Surg 213: 126–129, 1991
Camilleri IG, Malata CM, Stavrianos S, McLean NR: A review of 120 Becker permanent tissue expanders in reconstruction of the breast. Br J Plast Surg 49: 346–351, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caffo, O., Cazzolli, D., Scalet, A. et al. Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat 60, 267–275 (2000). https://doi.org/10.1023/A:1006401403249
Issue Date:
DOI: https://doi.org/10.1023/A:1006401403249